For Maria Rising, managing her health felt like chasing a phantom. The 30-year-old Lansing, Mich. consultant has for years ...
WEIGHT loss jabs have become the latest fad for changing your appearance. It seems as though half of Hollywood is using ...
Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetes. CATT1 Phase 3 trial expected to ...
IT’S hard to imagine a time when the word ‘Ozempic’ wasn’t part of our vocabulary.  For years, celebs have embraced the ...
Amid the soaring use of glucagon-like peptide-1 (GLP-1) drugs for intentional weight loss, a vastly different movement appears to be gaining traction in health care: Many clinicians are pushing for a ...
Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetes CATT1 Phase 3 trial expected to resume following submission of protocol amendment shortening the overall durati ...
Discover the causes behind fatty liver disease, a condition affecting 25% of adults worldwide, and learn simple lifestyle ...
Investing.com -- Shares of vTv Therapeutics Inc . (NASDAQ: VTVT) rose 15% after the company announced that the FDA has lifted the clinical hold on its Cadisegliatin program for diabetes. Trading had ...
As Netflix's new series Apple Cider Vinegar demonstrates, many wellness trends that may or may not have scientific backing ...